ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stratasys
SSYS
|
+$26.2M |
| 2 |
JD.com
JD
|
+$25.8M |
| 3 |
Tesla
TSLA
|
+$25.3M |
| 4 |
Intellia Therapeutics
NTLA
|
+$23.1M |
| 5 |
HAPN
Happen Inc
HAPN
|
+$18.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$6.48M |
| 2 |
BlackBerry
BB
|
+$4.55M |
| 3 |
Twilio
TWLO
|
+$3.67M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$3.58M |
| 5 |
FMI
Foundation Medicine, Inc.
FMI
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.34% |
| 2 | Healthcare | 19.56% |
| 3 | Communication Services | 14.61% |
| 4 | Consumer Discretionary | 14.22% |
| 5 | Industrials | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Allient
ALNT
$1.61B
| $1.21M | 0.1% |
54,867
+10,954
| +25% | +$223K |
|
77
Inovio Pharmaceuticals
INO
$68.5M
| $1.18M | 0.09% |
23,856
+11,907
| +100% | +$738K |
|
|
CSOD
78
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $1.18M | 0.09% |
33,434
+1,701
| +5% | +$63.4K |
|
|
79
BlackBerry
BB
$5.2B
| $1.18M | 0.09% |
105,161
-417,198
| -80% | -$4.55M |
|
80
Qualcomm
QCOM
$171B
| $1.16M | 0.09% |
18,147
+3,165
| +21% | +$192K |
|
81
Cognex
CGNX
$11.9B
| $1.1M | 0.09% |
+17,948
| New | +$1.14M |
|
82
Teladoc Health
TDOC
$1.22B
| $1.09M | 0.09% |
31,321
+21,274
| +212% | +$706K |
|
83
Albemarle
ALB
$14.2B
| $1.07M | 0.08% |
8,333
+2,380
| +40% | +$323K |
|
84
Incyte
INCY
$24.4B
| $1.04M | 0.08% |
11,004
+3,825
| +53% | +$400K |
|
85
Regeneron Pharmaceuticals
REGN
$78.3B
| $1.04M | 0.08% |
2,761
+530
| +24% | +$215K |
|
|
CELG
86
DELISTED
Celgene Corp
CELG
| $1.01M | 0.08% |
9,695
+7,216
| +291% | +$814K |
|
87
Plug Power
PLUG
$3.01B
| $973K | 0.08% |
412,391
+74,934
| +22% | +$192K |
|
|
FPRX
88
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $947K | 0.08% |
43,215
+21,211
| +96% | +$682K |
|
|
CFMS
89
DELISTED
Conformis, Inc. Common Stock
CFMS
| $930K | 0.07% |
15,623
+4,775
| +44% | +$382K |
|
90
Howmet Aerospace
HWM
$115B
| $751K | 0.06% |
35,929
+3,633
| +11% | +$70.7K |
|
91
CRISPR Therapeutics
CRSP
$5.23B
| $737K | 0.06% |
31,388
+5,833
| +23% | +$111K |
|
|
FARO
92
DELISTED
Faro Technologies
FARO
| $724K | 0.06% |
15,397
+3,362
| +28% | +$157K |
|
93
United Parcel Service
UPS
$92.7B
| $703K | 0.06% |
5,896
+428
| +8% | +$50.3K |
|
|
JNCE
94
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $678K | 0.05% |
53,176
+24,644
| +86% | +$362K |
|
95
Ametek
AME
$58.2B
| $643K | 0.05% |
8,870
+1,129
| +15% | +$78.7K |
|
96
Arcturus Therapeutics
ARCT
$177M
| $610K | 0.05% |
+76,737
| New | +$690K |
|
97
GE Aerospace
GE
$391B
| $596K | 0.05% |
7,123
+3,350
| +89% | +$320K |
|
98
Pacific Biosciences
PACB
$447M
| $565K | 0.05% |
213,917
+179,192
| +516% | +$627K |
|
|
UCTT
99
Ultra Clean Holdings
UCTT
$3.79B
| $549K | 0.04% |
23,758
-1,853
| -7% | -$47.5K |
|
100
Pluri
PLUR
$16.8M
| $401K | 0.03% |
3,637
+2,852
| +363% | +$356K |
|
Similar funds
ARK Investment Management's Q4 2017 Portfolio in Review
As of Q4 2017, ARK Investment Management held 211 positions worth $1.26B, up 53% from $819M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ARK Investment Management deployed $434M of net new capital in Q4 2017, opening 66 new positions and adding to 116 existing holdings. Its largest new stake was Cognex: 17,948 shares worth $1.1M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Akamai, an estimated $6.48M trimmed.
- ARK Investment Management's largest Q4 2017 buy was Cognex: 17,948 shares worth $1.1M.
- ARK Investment Management added most to Stratasys in Q4 2017, an estimated $26.2M increase.
- ARK Investment Management's biggest Q4 2017 reduction was Akamai, cutting an estimated $6.48M.
- ARK Investment Management fully exited Thermo Fisher Scientific in Q4 2017, selling an estimated $3.58M.
- ARK Investment Management's ten largest holdings make up 34% of its $1.26B portfolio in Q4 2017.
- ARK Investment Management opened 66 new positions and closed 11 in Q4 2017.
- ARK Investment Management's portfolio value rose 53% quarter-over-quarter to $1.26B.
Based on ARK Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.